Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
A session filmed at the 64th ASH Annual Meeting and Exposition congress, featuring experts Aaron Gerds and Lucia Masarova, who discuss clinical trial updates and novel treatment approaches in MPNs.
Welcome to The MPN Sessions brought to you by the Video Journal of Hematological Oncology (VJHemOnc). This exclusive discussion features leading experts Aaron Gerds, MD, Cleveland Clinic, Cleveland, OH, and Lucia Masarova, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, who discuss key updates in the treatment and management of myeloproliferative neoplasms (MPNs) at the 64th ASH Annual Meeting and Exposition congress. Topics covered include updates from the MOMENTUM trial (NCT04173494), the importance of combination approaches in MPNs, and novel agents in the field, including JAK inhibitors and calreticulin-targeting antibodies.
The MPN Channel on VJHemOnc is supported by Constellation Pharmaceuticals, Kartos Therapeutics, Inc. and Sierra Oncology.
These supporters have no influence over the production of the content.
